Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Unichem Laboratories Limited is a pharmaceutical company that manufactures active pharmaceutical ingredients (APIs or bulk actives).
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
1 month ago•The Hindu Businessline
1 month ago•Economic Times
1 month ago•Economic Times
Unichem Laboratories Limited has informed the Exchange about Copy of the Newspaper Publication - Financial Results for the quarter and year ended March 31, 2023 | Download
Unichem Laboratories Limited has informed the Exchange about Copy of the Newspaper Publication - Financial Results for the quarter and year ended March 31, 2023 | Download
Final • Div/Share: ₹ 4
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant